About Enhancer

Enhancer ID: E_02_0978
Species: human
Position : chr22:24236392-24237411
Biosample name:
Experiment class : Low throughput
Enhancer type: Enhancer
Disease: Rheumatoid arthritis
Pubmed ID:  21087445
Enhancer experiment: Luciferase Reporter Assay,PCR,EMSA,DNaseI-seq
Enhancer experiment description: DNase I hypersensitivity was used to identify potential hypersensitive sites (HS) across the MIF gene locus. Reporter gene assays were performed in different human cell lines with constructs containing the native or mutated HS element. Following phylogenetic and transcription factor binding profiling, electrophoretic mobility shift assay (EMSA) and RNA interference were performed and the effects of incubation with mithramycin, an antibiotic that binds GC boxes, were also studied. An HS centred on the first intron of MIF was identified. The HS acted as an enhancer in human T lymphoblasts (CEMC7A), human embryonic kidney cells (HEK293T) and human monocytic cells (THP-1), but not in a fibroblast-like synoviocyte (FLS) cell line (SW982) or cultured FLS derived from rheumatoid arthritis (RA) patients.

About Target gene

Target gene : MIF(GIF,GLIF,MMIF)
Strong evidence: --
Less strong evidence: Luciferase Reporter Assay,PCR,EMSA,DNaseI-seq
Target gene experiment description: DNase I hypersensitivity was used to identify potential hypersensitive sites (HS) across the MIF gene locus. Reporter gene assays were performed in different human cell lines with constructs containing the native or mutated HS element. Following phylogenetic and transcription factor binding profiling, electrophoretic mobility shift assay (EMSA) and RNA interference were performed and the effects of incubation with mithramycin, an antibiotic that binds GC boxes, were also studied. An HS centred on the first intron of MIF was identified. The HS acted as an enhancer in human T lymphoblasts (CEMC7A), human embryonic kidney cells (HEK293T) and human monocytic cells (THP-1), but not in a fibroblast-like synoviocyte (FLS) cell line (SW982) or cultured FLS derived from rheumatoid arthritis (RA) patients.

About TF

TF name : SP1(SP1)
TF experiment: Luciferase Reporter Assay,EMSA
TF experiment description: In order to determine whether Sp1 is recruited to the MIF intron 1 Enhancer, EMSA was performed using CEMC7A nuclear extract and a radiolabelled DNA probe of the 5?region of the intronic sequence.We were able to demonstrate that Sp1 bound this sequence, as competition with excess cold Sp1 consensus sequence and addition of Sp1-specific antibody resulted in the abrogation of a shifted complex.

About Function

Enhancer function : --
Enhancer function experiment: --
Enhancer function
experiment description:
--

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
SP1 Activation of gene expression by SREBF (SREBP) reactome 42
SP1 AndrogenReceptor netpath 167
SP1 AP-1 transcription factor network pid 71
SP1 C-MYB transcription factor network pid 87
SP1 Direct p53 effectors pid 141
SP1 E2F transcription factor network pid 77
SP1 EGFR1 netpath 475
SP1 FOXA1 transcription factor network pid 45
SP1 FOXA2 and FOXA3 transcription factor networks pid 45
SP1 FOXM1 transcription factor network pid 43
SP1 HIF-1-alpha transcription factor network pid 67
SP1 HIF-2-alpha transcription factor network pid 34
SP1 Huntington disease panther 113
SP1 IL2 signaling events mediated by STAT5 pid 30
SP1 IL4-mediated signaling events pid 66
SP1 Leptin netpath 98
SP1 Oncogene Induced Senescence reactome 30
SP1 p73 transcription factor network pid 80
SP1 PPARA activates gene expression reactome 113
SP1 Regulation of nuclear SMAD2/3 signaling pid 82
SP1 Regulation of Telomerase pid 70
SP1 RNA polymerase II transcribes snRNA genes reactome 70
SP1 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription reactome 32
SP1 TGF_beta_Receptor netpath 220
SP1 Validated targets of C-MYC transcriptional repression pid 63
SP1 Validated transcriptional targets of AP1 family members Fra1 and Fra2 pid 37
SP1 Validated transcriptional targets of TAp63 isoforms pid 54
SP1 TGF-beta signaling pathway kegg 82
SP1 Huntington's disease kegg 182
SP1 Hs_Corticotropin-releasing_hormone_signaling_pathway_WP2355_90017 wikipathways 41
SP1 Hs_Leptin_signaling_pathway_WP2034_89856 wikipathways 37
SP1 Hs_Interleukin-11_Signaling_Pathway_WP2332_79525 wikipathways 17
SP1 Hs_Integrated_Breast_Cancer_Pathway_WP1984_82941 wikipathways 122
SP1 Hs_Estrogen_signaling_pathway_WP712_78491 wikipathways 13
SP1 Hs_Sudden_Infant_Death_Syndrome_(SIDS)_Susceptibility_Pathways_WP706_86078 wikipathways 33
SP1 Hs_TGF-beta_Signaling_Pathway_WP366_90028 wikipathways 67
SP1 Hs_AGE-RAGE_pathway_WP2324_89798 wikipathways 27
SP1 Hs_Androgen_receptor_signaling_pathway_WP138_79958 wikipathways 27
SP1 Hs_EGF-EGFR_Signaling_Pathway_WP437_79266 wikipathways 107

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs